A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD, MS
Center for International Blood and Marrow Transplant Research
Study Director - Willem Klaasen
Xenikos, BV
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Be300
Brussels, Belgium
- Site Be301
Brussels, Belgium
- Site Be307
Ghent, Belgium
- Site Be305
Leuven, Belgium
- Site Be302
Liège, Belgium
- Site Be303
Yvoir, Belgium
- Site Hr320
Zagreb, Croatia
- Site Fr341
Angers, France
- Site Fr345
Créteil, France
- Site Fr346
La Tronche, France
- Site Fr355
Lille, France
- Sitefr354
Nantes, France
- Sitefr342
Paris, France
- Sitefr348
Paris, France
- Site Fr356
Pierre-Bénite, France
- Site Fr351
Saint-Priest-en-Jarez, France
- Site Fr352
Toulouse, France
- Site De367
Dresden, Germany
- Site De364
Essen, Germany
- Site De371
Hanover, Germany
- Site De368
Heidelberg, Germany
- Site De360
Leipzig, Germany
- Site De362
Mainz, Germany
- Site De361
Münster, Germany
- Site It384
Milan, Italy
- Site Nl461
Groningen, Netherlands
- Site Nl460
Maastricht, Netherlands
- Site Nl463
Nijmegen, Netherlands
- Site Es447
Barcelona, Spain
- Site Es446
Madrid, Spain
- Site Es442
Salamanca, Spain
- Site Es451
Santander, Spain
- Site Es452
Seville, Spain
- Site Es453
Valencia, Spain
- Site Es454
Valencia, Spain
- Site Gb483
Cardiff, United Kingdom
- University of Alabama
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Washington University St. Louis
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Jun 2022
- Primary completion
- 10 Nov 2022
- Completion
- 19 Jan 2023
- Last update posted
- 27 Aug 2024
- Registered enrollment
- 12
- Registry id
- NCT04934670
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.